永胜医疗(01612.HK)附属与Vyaire订立供应协议以加强业务关系
格隆汇9月5日丨永胜医疗(01612.HK)发布公告,VMHK(公司间接非全资附属公司)与Vyaire已订立日期为2019年9月4日的供应协议,据此,VMHK将会按协定的规格向Vyaire供应该等产品,而Vyaire将会按其于供应协议期间内可能不时订购的有关数量向VMHK购买该等产品,供Vyaire自身使用或直接或间接转售予Vyaire的客户。本公司乃于2019年9月5日交易时段后接获供应协议的签字页。供应协议由2019年9月4日起至2024年9月3日止五年期间内有效。
Vyaire是一家全球领先的呼吸及麻醉医疗保健公司,致力开发通气、气道管理、呼吸诊断及手术护理解决方案。Vyaire拥有近27,000种产品,其品牌包括Bird、Bear、JAEGER、AirLife?、VitalSigns及Viasys。该公司的总部设于美国伊利诺州的梅塔瓦。
公司称,以截至2018年12月31日止年度的收益贡献计,Vyaire是本集团第二大客户。鉴于本集团与Vyaire的长期业务关系,以及由于根据供应协议生产及供应该等产品是本集团业务的必要部份,董事认为供应协议将让本集团能够加强与Vyaire的业务关系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.